loader2
Partner With Us NRI

Narayana Hrudayalaya Ltd share Price Today

Company details

1,227.20
1,252.65
968.00
1,444.90
6M Return 5.91%
1Y Return 29.48%
Mkt Cap.(Cr) 25,285.59
Volume 309,375
Div Yield 0.32%
OI
-
OI Chg %
-
Volume 309,375

Open Free Trading Account Online with ICICIDIRECT

Incur '0' Brokerage upto ₹500
Steady quarter amid seasonality; focus on new capex
About The Stock

    Narayana Hrudayalaya operates a chain of multispecialty, tertiary & primary healthcare facilities that initially focused on cardiac & renal but expanded to cancer, neurology, neurosurgery, orthopaedics and gastroenterology facilities.

    • NHL’s network comprises 21 hospitals (including two managed hospitals), four heart centres, 18 primary care facilities (including clinics and information centres) and a multi-speciality hospital in Cayman Islands)
    • Revenue mix Q3FY23 – India: ₹ 928.3 crore; (Bengaluru:35%, Southern Peripheral: 6%, Kolkata:26%, Eastern Peripheral: 10%, Western: 5%, Northern: 18%); Cayman Islands: US$ 28.2 million
Q3FY23 Results

    Steady performance across segments with margins beat.

    • Revenues de-grew 1.2% QoQ to ₹ 1128.2 crore as hospitals in India de-grew 2.4% QoQ followed by Cayman Islands, which de-grew 2.2% QoQ
    • EBITDA grew 4.4% QoQ to ₹ 254.4 crore. EBITDA margins grew 121 bps QoQ to 22.6%
    • Adjusted PAT declined 8.9% QoQ to ₹ 153.8 crore

Click here for full recommendation

Research view on more stocks

Healthcare Facilities company Narayana Hrudayalaya announced Q4FY24 & FY24 results:

Q4FY24 Financial Highlights:

  • Consolidated total operating revenue was Rs 12,794 million for Q4 FY24 as compared to Rs 12,216 million in the corresponding period of the previous year, reflecting a growth of 4.7 % YoY and 6.3% QoQ.
  • Consolidated EBITDA* stood at Rs 3,184 million, reflecting a margin of 24.9% as against Rs 2,904 million in Q4 FY23, translating into a growth of 9.7% YoY and 7.3% QoQ.
  • Consolidated PAT* stood at Rs 1,908 million, reflecting a margin of 14.9% as compared to Rs 1,732 million in Q4 FY23, translating into growth of 10.2% YoY and 1.4% QoQ.
  • India operating revenue was Rs 10,352 million for Q4 FY24 as compared to Rs 9,842 million in the corresponding period of the previous year, reflecting a growth of 5.2% YoY and 7.9% QoQ.
  • Cayman operating revenue was Rs 2,528 million for Q4 FY24 as compared to Rs 2,445 million in the corresponding period of the previous year, reflecting a growth of 3.4% YoY and -1.9% QoQ.

FY24 Financial Highlights:

  • Consolidated total operating revenue was Rs 50,183 million for FY24 as compared to Rs 45,248 million in FY 23, reflecting a growth of 10.9 %.
  • Consolidated EBITDA stood at Rs 12,275 million for FY24, reflecting a margin of 24.5% as against Rs 10,313 million in FY23, reflecting a growth of 19.0%.
  • Consolidated PAT stood at Rs 7,896 million for FY24, reflecting a margin of 15.7% as compared to Rs 6,066 million in FY23.
  • India operating revenue was Rs 40,365 million for FY24 as compared to Rs 36,774 million in FY23, reflecting a growth of 9.8%.
  • Cayman operating revenue was Rs 10,261 million for FY24 as compared to Rs 8,824 million in FY23, reflecting a growth of 16.3%. 

Commenting on the performance, Emmanuel Rupert, Managing Director and Group CEO, Narayana Hrudayalaya Limited, said “The current financial year exhibited strong momentum; we are pleased to report the highest-ever revenue and profitability margins for the financial year, which is on account of improvement in realizations, payor mix and increased patient footfalls during the year. The performance improvement is supported by strong growth in business across our flagship units, other hospitals, and steady improvements in performance of our newer hospitals. HCCI continues to deliver record performance on both revenue and profitability for the current financial year. NHIC has delivered another strong quarter of increased patient transactions. We are confident of delivering on our expectations for the upcoming year.

Result PDF

View Other Company Results

Narayana Hrudayalaya Ltd shares SWOT Analysis

Strengths (4)

  • Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
  • Annual Net Profits improving for last 2 years
  • Book Value per share Improving for last 2 years

Weakness (1)

  • MFs decreased their shareholding last quarter

Opportunity (1)

  • Negative to Positive growth in Sales and Profit with Strong Price momentum

Threats (1)

  • Increasing Trend in Non-Core Income

Resistance and support

R1 1,250.9
R2 1,264.5
R3 1,276.4
Pivot

1,239.05

S1 1,225.5
S2 1,213.6
S3 1,200.0
EMA SMA
1,235.9
1,247.5
1,243.4
1,184.3
1,229.8
1,254.8
1,278.0
1,200.6
Delivery and volume
CLIENT NAME DEAL TYPE ACTION DATE AVG. PRICE QUANTITY EXCHANGE
ISHARES CORE MSCI EMERGING MARKETS ETF Block Purchase 2022-10-17 729.7 176557 BSE
ISHARES MSCI INDIA SMALL-CAP ETF Block Purchase 2022-10-17 729.7 24703 BSE
ISHARES CORE EMERGING MARKETS MAURITIUS CO Block Sell 2022-10-17 729.7 176557 BSE
Name Category Shares
SHAKUNTALA SHETTY PROMOTER 30.38%
DEVI PRASAD SHETTY PROMOTER 11.66%
AMEYA SHETTY PROMOTER 5%
ANESH SHETTY PROMOTER 5%
VARUN SHETTY PROMOTER 5%
VIREN PRASAD SHETTY PROMOTER 5%
Narayana Health Academy Private Limited PROMOTER 1.81%

OUR RESEARCH VIEW

Investment recommendation
Steady quarter amid seasonality; focus on new capex
Call Date
11 Feb 2023
Entry Price 717.00
Target Price 870.00
Duration
12-18 Month

FINANCIALS

Sales
Operating Profit
Profit after Tax
Equity
Reserves and Surplus
Debt
Sales
Operating Profit
Profit after Tax
PE
Debt/Equity
P BV

Narayana Hrudayalaya Ltd Stocks COMPARISON

Financials( in Cr) Narayana Hrudayalaya Ltd Max Healthcare Institute Ltd Apollo Hospitals Enterprise Ltd Fortis Healthcare Ltd Global Health Ltd
Price 1,237.30 927.90 6,207.60 502.25 1,356.20
% Change 0.88 4.25 0.02 3.99 6.17
Mcap Cr 25,285.59 90,183.71 89,255.98 37,917.77 36,414.92
Revenue TTM Cr 4,524.77 4,831.37 16,612.50 6,537.06 2,694.25
Net Profit TTM Cr 606.57 1,103.51 887.50 632.98 326.08
PE TTM 32.04 85.36 99.43 64.55 76.14
1 Year Return 29.48 60.94 25.38 74.57 116.27
ROCE 29.27 13.85 14.16 7.51 16.49
ROE 33.51 16.12 15.04 6.79 16.13
INSIDER & INSTITUTIONAL ACTIVITY

Equity Capital: 2,132.67 Cr FV: 10.00

Period MF Net Purchase / (sold) FII Net
LAST 1M 34,088.77 -1,030.79
LAST 3M 113,155.52 -39,495.50
LAST 6M 184,812.44 -13,263.60
LAST 12M 291,038.85 99,015.20
Narayana Hrudayalaya AGM scheduled

Jun 14, 2024 l BSE Announcement

Narayana Hrudayalaya Ltd. - Analysts/Institutional Investor Meet/Con. Call Updates

Jun 13, 2024 l NSE Announcement

Narayana Hrudayalaya Ltd. - Analysts/Institutional Investor Meet/Con. Call Updates

Jun 12, 2024 l NSE Announcement

Date Action Type Ratio
Jul 07, 2023 Dividend 25
Aug 22, 2022 Dividend 10

Narayana Hrudayalaya Ltd Information

Stock PE (TTM)
32.04
Promoter Holding
63.85%
Book Value
141.1073
ROCE
29.27%
ROE
33.51%
Description
  • Narayana Hrudayalaya runs a chain of multi-speciality hospitals located across India. The company also operates primary care facilities, heart centres, and other healthcare facilities. The company has its headquarters in Bengaluru. Narayana Health was started by Dr Devi Shetty in 2000. As on 19 December 2022,  the company employs more than 11,000 professionals a year.

    On 19 December 2022, the market capitalisation of the company was Rs 15,434.35 crore. It reported consolidated sales of Rs 746.55 crore at the end of September 2022. The company is listed on the Bombay Stock Exchange with the code 539551 and the National Stock Exchange with the code NH.

    The promoters of Narayana Health currently hold approximately 63.85% of the company. The foreign institutional investors’ investment in the company amounts to 14.16%. Various mutual funds hold around 13.43% of the company. The total public stake in the company is approximately 8.3%. The stake of the public has grown steadily over the past year (Since September 2021).

    Dr Devi Prasad Shetty is the chairman of the company and a whole-time director, and Emmanuel Rupert is the CEO and managing director. Viren Prasad Shetty, Kiran Mazumdar Shaw, Arun Seth, Dinesh Krishnaswamy, and TS Bresenham are the other directors of the company. Deloitte, Haskins, & Sells LLP are the auditors of Narayana Health. As of December 2022, the company had around 20.4 crore shares outstanding.

    On 19 December 2022, Narayana Health’s share price on NSE was Rs 754.2 and Rs 753.3 on BSE. The share price touched a 52-week high of Rs 810.5 and a 52-week low of Rs 545.1. Its three-month return to investors was 8.64%, while its one-year return was 32.54%. The company’s total operating income grew 12.3% quarter-on-quarter during the fourth quarter of FY22.

    As of November 2022, Axis Small Cap Direct-G has invested Rs 501.1 crore in the company. Other prominent mutual funds with investments in Naryana include SBI Small Cap Direct-G, with an investment of Rs 266.8 crore, and Nippon India Pharma Direct-G, with an investment of Rs 221.4 crore in the company.

    Some of Narayana's peers include Max Healthcare, Fortis Healthcare, and Krishna Institute of Medicine.

    Disclaimer: ICICI Securities Ltd. (I-Sec). Registered office of I-Sec is at ICICI Securities Ltd. - ICICI Venture House, Appasaheb Marathe Marg, Prabhadevi, Mumbai - 400 025, India, Tel No : 022 - 6807 7100. I-Sec is a Member of National Stock Exchange of India Ltd (Member Code: 07730), BSE Ltd (Member Code: 103) and Member of Multi Commodity Exchange of India Ltd.(Member Code: 56250) and having SEBI registration no. INZ000183631. Name of the Compliance officer (broking): Ms. Mamta Shetty, Contact number: 022-40701022, E-mail address: complianceofficer@icicisecurities.com. Investments in securities market are subject to market risks, read all the related documents carefully before investing. The contents herein above shall not be considered as an invitation or persuasion to trade or invest. I-Sec and affiliates accept no liabilities for any loss or damage of any kind arising out of any actions taken in reliance thereon. Such representations are not indicative of future results. The securities quoted are exemplary and are not recommendatory. Investors should consult their financial advisers if in doubt about whether the product is suitable for them. The contents herein above are solely for informational purpose and may not be used or considered as an offer document or solicitation of offer to buy or sell or subscribe for securities or other financial instruments or any other product. Investors should consult their financial advisers whether the product is suitable for them before taking any decision. The contents herein mentioned are solely for informational and educational purpose.

Registered Address

No 258/A Bommasandra Indl Area, Anekal Taluq, Bengaluru, Karnataka, 560099

Tel : 91-80-71222802
Email : investorrelations:narayanahealth.org
Website : http://www.narayanahealth.org
Registrar

KFin Techologies Ltd

AGM Date (Month) : Aug
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 539551
NSE Code : NH
Book Closure Date (Month) :
BSE Group : A
ISIN : INE410P01011

FAQ’s on Narayana Hrudayalaya Ltd Shares

You can buy Narayana Hrudayalaya Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Narayana Hrudayalaya Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of Jun 14, 2024 03:59 PM the closing price of Narayana Hrudayalaya Ltd was Rs.1,237.30.

The latest PE ratio of Narayana Hrudayalaya Ltd as of Jun 14, 2024 03:59 PM is 32.04

The latest PB ratio of Narayana Hrudayalaya Ltd as of Jun 14, 2024 03:59 PM is 0.11

The 52-week high of Narayana Hrudayalaya Ltd share price is Rs. 1,444.90 while the 52-week low is Rs. 968.00

According to analyst recommendations, Narayana Hrudayalaya Ltd Share has a "Buy" rating for the long term.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of Jun 14, 2024 03:59 PM, the market cap of Narayana Hrudayalaya Ltd stood at Rs. 25,285.59.

Download App

Download Our App

Play Store App Store
market app